DrugPatentWatch Database Preview

Sagent Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?

SAGENT PHARMS has sixty-five approved drugs.

There is one tentative approval on SAGENT PHARMS drugs.

Summary for Sagent Pharms

US Patents:	0
Tradenames:	52
Ingredients:	50
NDAs:	65

Drugs and US Patents for Sagent Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sagent Pharms	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	091597-001	May 7, 2013		DISCN	No	No
Sagent Pharms	LINEZOLID	linezolid	SOLUTION;INTRAVENOUS	204696-002	Mar 2, 2017	AP	RX	No	No
Sagent Pharms	PAMIDRONATE DISODIUM	pamidronate disodium	INJECTABLE;INJECTION	078373-002	Dec 23, 2008	AP	RX	No	No
Sagent Pharms	OCTREOTIDE ACETATE	octreotide acetate	INJECTABLE;INJECTION	091041-002	Nov 12, 2013	AP	RX	No	No
Sagent Pharms	FLUMAZENIL	flumazenil	INJECTABLE;INJECTION	090584-002	Aug 28, 2012	AP	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Sage Prods
• Sagent Pharms
• Sagent Strides